(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of 18.76% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.22%.
Mdxhealth Sa's revenue in 2025 is $98,953,000.On average, 7 Wall Street analysts forecast MDXH's revenue for 2025 to be $5,561,520,448, with the lowest MDXH revenue forecast at $5,263,051,524, and the highest MDXH revenue forecast at $5,966,408,640. On average, 7 Wall Street analysts forecast MDXH's revenue for 2026 to be $6,740,546,944, with the lowest MDXH revenue forecast at $6,065,403,308, and the highest MDXH revenue forecast at $8,076,479,989.
In 2027, MDXH is forecast to generate $8,302,682,805 in revenue, with the lowest revenue forecast at $7,033,571,161 and the highest revenue forecast at $9,557,935,195.